| Title |
Ivermectin for onchocercal eye disease (river blindness)
|
|---|---|
| Published in |
Cochrane database of systematic reviews, August 2012
|
| DOI | 10.1002/14651858.cd002219.pub2 |
| Pubmed ID | |
| Authors |
Henry OD Ejere, Ellen Schwartz, Richard Wormald, Jennifer R Evans |
| Abstract |
It is believed that ivermectin (a microfilaricide) could prevent blindness due to onchocerciasis. However, when given to everyone in communities where onchocerciasis is common, the effects of ivermectin on lesions affecting the eye are uncertain and data on whether the drug prevents visual loss are unclear. |
X Demographics
The data shown below were collected from the profiles of 24 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| France | 5 | 21% |
| United States | 4 | 17% |
| United Kingdom | 1 | 4% |
| Unknown | 14 | 58% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 22 | 92% |
| Practitioners (doctors, other healthcare professionals) | 1 | 4% |
| Scientists | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 133 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 2% |
| Brazil | 1 | <1% |
| Unknown | 130 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 21 | 16% |
| Student > Bachelor | 18 | 14% |
| Student > Master | 16 | 12% |
| Student > Ph. D. Student | 11 | 8% |
| Student > Postgraduate | 9 | 7% |
| Other | 19 | 14% |
| Unknown | 39 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 45 | 34% |
| Social Sciences | 10 | 8% |
| Nursing and Health Professions | 7 | 5% |
| Agricultural and Biological Sciences | 7 | 5% |
| Psychology | 5 | 4% |
| Other | 18 | 14% |
| Unknown | 41 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 27. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 November 2023.
All research outputs
#1,452,009
of 25,595,500 outputs
Outputs from Cochrane database of systematic reviews
#3,128
of 13,156 outputs
Outputs of similar age
#8,471
of 186,440 outputs
Outputs of similar age from Cochrane database of systematic reviews
#50
of 218 outputs
Altmetric has tracked 25,595,500 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,156 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 186,440 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 218 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.